Patents Assigned to BARD1 LIFE SCIENCES LIMITED
  • Patent number: 11193944
    Abstract: The present invention relates to a method for the accurate, rapid and sensitive detection of breast or ovarian cancers from body fluid samples of a mammalian subject and related assay, kits and peptides suitable for such a method.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: December 7, 2021
    Assignee: BARD1 LIFE SCIENCES LIMITED
    Inventors: Solomzi Makohliso, Irmgard Irminger-Finger, Fernando Herrera
  • Patent number: 10273475
    Abstract: The present invention relates to a long non-coding BARD1 RNA molecule named BARD1 9?L. The present invention also relates to siRNAs for therapeutic use, for example, the regulation of BARD1 expression by non-coding RNA. The present invention further relates to methods for the detection of BARD1 9?L. Finally, the present invention relates to promoters driving the expression of BARD1 9?L.
    Type: Grant
    Filed: July 12, 2015
    Date of Patent: April 30, 2019
    Assignee: BARD1 LIFE SCIENCES LIMITED
    Inventors: Irmgard Irminger-Finger, Maxim Pilyugin
  • Publication number: 20190119680
    Abstract: The invention relates to the novel long non-coding BARD1 RNA molecule BARD1 9?L, siRNAs for therapeutic use and methods for the detection of BARD1 9?L as well as a promoters driving the expression of BARD1 9?L.
    Type: Application
    Filed: January 4, 2019
    Publication date: April 25, 2019
    Applicant: BARD1 LIFE SCIENCES LIMITED
    Inventors: Irmgard IRMINGER-FINGER, Maxim Pilyugin
  • Publication number: 20180306808
    Abstract: The present invention relates to a method for the accurate, rapid and sensitive detection of breast or ovarian cancers from body fluid samples of a mammalian subject and related assay, kits and peptides suitable for such a method.
    Type: Application
    Filed: June 13, 2018
    Publication date: October 25, 2018
    Applicant: BARD1 LIFE SCIENCES LIMITED
    Inventors: Solomzi MAKOHLISO, Irmgard IRMINGER-FINGER, Fernando HERRERA
  • Patent number: 10018639
    Abstract: The present invention relates to a method for the accurate, rapid and sensitive detection of breast or ovarian cancers from body fluid samples of a mammalian subject and related assay, kits and peptides suitable for such a method.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: July 10, 2018
    Assignee: BARD1 LIFE SCIENCES LIMITED
    Inventors: Solomzi Makohliso, Irmgard Irminger-Finger, Fernando Herrera